These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17489714)

  • 1. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers.
    Zito JM; Safer DJ; Valluri S; Gardner JF; Korelitz JJ; Mattison DR
    J Child Adolesc Psychopharmacol; 2007 Apr; 17(2):195-203. PubMed ID: 17489714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant treatment for psychiatric and seizure indications among youths.
    Zito JM; Safer DJ; Gardner JF; Soeken K; Ryu J
    Psychiatr Serv; 2006 May; 57(5):681-5. PubMed ID: 16675763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National trends in pediatric use of anticonvulsants.
    Tran AR; Zito JM; Safer DJ; Hundley SD
    Psychiatr Serv; 2012 Nov; 63(11):1095-101. PubMed ID: 22983637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program.
    Constantine RJ; Tandon R; McPherson M; Andel R
    J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):79-84. PubMed ID: 21288122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the prescribing of psychotropic medications to preschoolers.
    Zito JM; Safer DJ; dosReis S; Gardner JF; Boles M; Lynch F
    JAMA; 2000 Feb; 283(8):1025-30. PubMed ID: 10697062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Early Mental Health Diagnosis and Medication Treatment in a Medicaid-Insured Birth Cohort.
    Pennap D; Zito JM; Santosh PJ; Tom SE; Onukwugha E; Magder LS
    JAMA Pediatr; 2018 Jun; 172(6):576-584. PubMed ID: 29710205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
    Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
    Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
    Martin A; Leslie D
    Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.
    Zito JM; Burcu M; Ibe A; Safer DJ; Magder LS
    Psychiatr Serv; 2013 Mar; 64(3):223-9. PubMed ID: 23242390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic medication use among Kansas Medicaid youths with disabilities.
    Shireman TI; Reichard A; Rigler SK
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):107-15. PubMed ID: 15741792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic practice patterns for youth: a 10-year perspective.
    Zito JM; Safer DJ; DosReis S; Gardner JF; Magder L; Soeken K; Boles M; Lynch F; Riddle MA
    Arch Pediatr Adolesc Med; 2003 Jan; 157(1):17-25. PubMed ID: 12517190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees.
    Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS
    J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275
    [No Abstract]   [Full Text] [Related]  

  • 16. Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark.
    Steinhausen HC; Bisgaard C
    Acta Psychiatr Scand; 2014 Mar; 129(3):221-31. PubMed ID: 23738593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population.
    Chen H; Deshpande AD; Jiang R; Martin BC
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):629-38. PubMed ID: 15597329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple psychotropic medication use for youths: a two-state comparison.
    dosReis S; Zito JM; Safer DJ; Gardner JF; Puccia KB; Owens PL
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):68-77. PubMed ID: 15741788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of a State Medicaid Peer-Review Authorization Program on Pediatric Use of Antipsychotic Medications.
    Pennap D; Burcu M; Safer DJ; Zito JM
    Psychiatr Serv; 2018 Mar; 69(3):293-299. PubMed ID: 29137557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
    Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
    J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.